Browse by Medical Category
Research at Mass General
Dr. Tanya Keenan grew up outside of Philadelphia and completed a B.S. in Neuroscience and a B.A. in Political Science at the University of Pittsburgh. She then returned to Philadelphia to attend medical school at the University of Pennsylvania. Before graduating from medical school, Dr. Keenan also earned a Master’s of Public Health from the Johns Hopkins Bloomberg School of Public Health. She then moved to Boston for residency in Internal Medicine at Massachusetts General Hospital. Dr. Keenan is currently applying for Hematology-Oncology fellowships and hopes to stay in Boston at the combined Dana Farber Cancer Institute, Brigham & Women’s Hospital, and Massachusetts General Hospital program.
Dr. Keenan is passionate about investigating breast cancer disparities and end of life care in her future career as a breast oncologist. She looks forward to an academic career dedicated to catalyzing widespread progress in healthcare equity and end of life care for breast cancer patients. Her professional aspiration is to better identify minority patients with breast cancer, engage them in precision medicine and epigenetics research, and develop discovery and access pathways for novel therapeutics for types of breast cancer, such as triple negative breast tumors, that disproportionately affect minority patients. Dr. Keenan will also evaluate quality of care in breast cancer patients near the end of life and investigate interventions to help breast cancer patients better achieve their end of life goals.
October 25, 2015 - WCVB 5 Boston
A new study at the Mass General Hospital Cancer Center has found a genomic difference between breast cancers of African American and white women. Tanya Keenan, MD, at MGH Cancer Center and lead author of the study joins us to discuss what this means for African American women and what they can do to take precautions. Watch the interview here.
Back to Top